Some natural compounds enhance Nε-(carboxymethyl)lysine formation

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 152-154

  Fujiwara, Yukio ^a   Kiyota, Naoko ^a   Motomura, Keita ^a   Mera, Katsumi ^a   Takeya, Motohiro ^a   Ikeda, Tsuyoshi ^a   Nagai, Ryoji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Anti AGE antibody; N (carboxymethyl)lysine; Natural compounds

Indexed keywords

ACTEOSIDE; BOVINE SERUM ALBUMIN; DEGALACTOTIGONIN; LYSINE; N OMEGA (CARBOXYMETHYL)LYSINE; NATURAL PRODUCT; NEOASPIDISTRIN; QUERCETIN; RIBOSE;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE INACTIVATION; INCUBATION TIME; NONHUMAN;

BOVINAE; RATTUS;

EID: 42549152386     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.015     Document Type: Conference Paper

References (9)

1. 1 Kume, S. et al. 1995. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147: 654–667.
2. 2 Nagai, R. et al. 2002. Peroxynitrite induces formation of N(epsilon)‐(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 51: 2833–2839.
3. 3 Mera, K. et al. 2007. Hypochlorous acid generates N epsilon‐(carboxymethyl)lysine from Amadori products. Free Radic Res. 41: 713–718.
4. 4 Metz, T.O. et al. 2003. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch. Biochem. Biophys. 419: 41–49.
5. 5 Yan, W. et al. 1996. Steroidal saponins from fruits of Tribulus terrestris. Phytochemistry 42: 1417–1422.
6. 6 Takeda, Y. et al. 1998. An acyclic monoterpene glucosyl ester from Lantana lilacia. Planta Med. 64: 78–79.
7. 7 Hammes, H.P. et al. 2003. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med. 9: 294–299.
8. 8 Babaei‐Jadidi, R. et al. 2004. High‐dose thiamine therapy counters dyslipidaemia in streptozotocin‐induced diabetic rats. Diabetologia 47: 2235–2246.
9. 9 Alikhani, Z. et al. 2005. Advanced glycation end products enhance expression of pro‐apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J. Biol. Chem. 280: 12087–12095.